Kyntra Bio, Inc. (KYNB)
4.65
-0.07
(-1.48%)
USD |
NASDAQ |
Oct 29, 16:00
4.55
-0.10
(-2.15%)
After-Hours: 20:00
Kyntra Bio Total Return Level : 4.65 for Oct. 29, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 29, 2026 | 4.65 |
| October 28, 2026 | 4.72 |
| October 27, 2026 | 4.50 |
| October 26, 2026 | 4.50 |
| October 23, 2026 | 4.580 |
| October 22, 2026 | 5.22 |
| October 21, 2026 | 5.21 |
| October 20, 2026 | 5.28 |
| October 19, 2026 | 5.28 |
| October 16, 2026 | 4.85 |
| October 15, 2026 | 5.36 |
| October 14, 2026 | 5.565 |
| October 13, 2026 | 5.87 |
| October 12, 2026 | 6.12 |
| October 09, 2026 | 6.11 |
| October 08, 2026 | 5.96 |
| October 07, 2026 | 6.13 |
| October 06, 2026 | 5.96 |
| October 05, 2026 | 6.09 |
| October 02, 2026 | 6.31 |
| October 01, 2026 | 6.50 |
| September 30, 2026 | 6.65 |
| September 29, 2026 | 6.79 |
| September 28, 2026 | 6.90 |
| September 25, 2026 | 6.94 |
| Date | Value |
|---|---|
| September 24, 2026 | 7.00 |
| September 23, 2026 | 7.25 |
| September 22, 2026 | 7.28 |
| September 21, 2026 | 7.20 |
| September 18, 2026 | 7.075 |
| September 17, 2026 | 7.10 |
| September 16, 2026 | 7.61 |
| September 15, 2026 | 7.77 |
| September 14, 2026 | 8.03 |
| September 11, 2026 | 7.97 |
| September 10, 2026 | 7.975 |
| September 09, 2026 | 8.04 |
| September 08, 2026 | 8.22 |
| September 04, 2026 | 8.55 |
| September 03, 2026 | 8.49 |
| September 02, 2026 | 8.53 |
| September 01, 2026 | 7.95 |
| August 31, 2026 | 7.78 |
| August 28, 2026 | 8.02 |
| August 27, 2026 | 8.00 |
| August 26, 2026 | 8.105 |
| August 25, 2026 | 8.10 |
| August 24, 2026 | 7.98 |
| August 21, 2026 | 7.52 |
| August 20, 2026 | 7.32 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Vericel Corp. | 42.91 |
| Nektar Therapeutics | 39.18 |
| Capricor Therapeutics, Inc. | 6.63 |
| ARS Pharmaceuticals, Inc. | 3.66 |
| ACADIA Pharmaceuticals, Inc. | 20.76 |